Table 1.
Patient baseline demographics
| Variable | Overall (N = 154) | Asymptomatic (n = 17) | Mildly symptomatic (n = 48) | Moderately symptomatic (n = 50) | Severely symptomatic (n = 39) |
|---|---|---|---|---|---|
| Male (n (%)) | 97 (63) | 12 (71) | 31 (65) | 27 (54) | 27 (69) |
| Age (mean ± SD, years) | 66.4 ± 10.0 | 66.9 ± 11.0 | 66.0 ± 8.9 | 67.4 ± 10.3 | 65.5 ± 10.8 |
| Nationality (n (%)) | |||||
| British | 73 (47) | 5 (29) | 27 (56) | 29 (58) | 12 (31) |
| German | 56 (36) | 12 (71) | 11 (23) | 15 (30) | 18 (46) |
| Other | 25 (16) | 0 | 10 (21) | 6 (12) | 9 (23) |
| Comorbidities present at the time of the visit (n (%)) | |||||
| None | 49 (32) | 6 (35) | 17 (35) | 19 (38) | 7 (18) |
| 1 | 44 (29) | 6 (35) | 15 (31) | 17 (34) | 6 (15) |
| 2 | 24 (16) | 5 (29) | 6 (13) | 5 (10) | 8 (21) |
| ≥3 | 37 (24) | 0 | 10 (21) | 9 (18) | 18 (46) |
| Duration of MM (mean ± SD, years) | 3.7 ± 3.7 | 3.3 ± 3.3 | 3.6 ± 3.9 | 4.2 ± 3.7 | 3.6 ± 3.4 |
MM multiple myeloma, SD standard deviation